DHTL — Docmode Health Technologies Income Statement
0.000.00%
- IN₹70.08m
- IN₹104.65m
- IN₹255.16m
Annual income statement for Docmode Health Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 124 | — | 400 | 418 | 255 |
| Cost of Revenue | |||||
| Gross Profit | 106 | — | 371 | 56.6 | 56.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 106 | 109 | 381 | 427 | 261 |
| Operating Profit | 18.6 | — | 18.6 | -9.76 | -5.72 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 15 | — | 3.4 | -19.7 | -1.42 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.22 | — | 1.88 | -20.3 | -1.35 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.22 | — | 1.88 | -20.3 | -1.35 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.22 | — | 1.88 | -20.3 | -1.35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.93 | — | 0.597 | -6.45 | -0.429 |